NCT06774001 A Global Prospective Cohort Study on Outcomes of Appendicectomy for Appendicitis
| NCT ID | NCT06774001 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Birmingham |
| Condition | Appendicitis |
| Study Type | OBSERVATIONAL |
| Enrollment | 14,000 participants |
| Start Date | 2025-02-03 |
| Primary Completion | 2025-05-25 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 14,000 participants in total. It began in 2025-02-03 with a primary completion date of 2025-05-25.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study aims to assess and improve the global management of appendicitis, the most common emergency surgery, by examining various aspects of emergency care systems worldwide. Appendicitis is a time-sensitive condition, and delays in diagnosis or treatment can lead to complications, affecting patient outcomes and increasing healthcare costs. The study uses appendicitis as a "tracer condition" to explore how different healthcare systems manage emergency care, focusing on factors like access, quality, and efficiency. By gathering data from hospitals worldwide, the study seeks to identify areas where emergency surgical care can be improved, particularly in low- and middle-income countries (LMICs). The main goal is to identify gaps in emergency care systems, using a set of key performance measures (KPMs) that assess access to care, the quality of surgical treatment, and patient safety. These include factors like the time from symptom onset to first surgical assessment, the rate of appendectomy performed via minimally invasive (laparoscopic) surgery, and postoperative complications. The study aims to collect data on at least 14,000 patients from around 500 hospitals globally between February and May 2025. The data will be analyzed by hospital income group (from low to high) to understand how different resource levels impact outcomes and to help guide future policy and practice improvements. The study also includes two sub-studies that focus on specific issues in surgical care. The Sustainability and Waste Management sub-study aims to explore how hospitals manage waste and sustainability practices in operating theatres. This sub-study is part of global efforts to reduce carbon emissions in healthcare settings. The Financing sub-study examines the financial burden of appendicectomy, particularly the out-of-pocket costs for patients in LMICs. It will explore how the costs of open vs. laparoscopic surgery differ and investigate the impact of these costs on patients. By combining global data on clinical outcomes with information on hospital resources and patient finances, this study hopes to provide valuable insights into how to improve emergency surgical care across diverse settings, making recommendations that can lead to better access to safe, timely, and affordable treatment for appendicitis worldwide.
Eligibility Criteria
Inclusion Criteria: * Age: There are no age restrictions, although, if appropriate participating hospitals can choose to only include children or only adults, based on an age cut-off of their choice. * Procedure: All patients undergoing appendicectomy for suspected or confirmed appendicitis by any surgical approach should be included. This includes patients who went theatre with suspect appendicitis even if the intraoperative or pathology results found a different diagnosis, so long as an appendicectomy was performed. It also includes patients who went to theatre for reasons other than suspected appendicitis but were found to have appendicitis intraoperatively and underwent appendicectomy. This includes interval appendicectomy and right hemicolectomy if performed for acute appendicitis. * Approach: Both open and minimally invasive (laparoscopic and robotic) interventions are eligible for inclusion. Laparoscopic and robotic converted to open cases are also eligible. Exclusion Criteria: * Indication: Appendicectomy for any indication other than suspected or confirmed appendicitis should be excluded. For example, patients having appendicectomy for known appendiceal neoplasm. * Procedure: Patients having appendectomy as part of another surgical procedure should be excluded. For example, patients having removal of appendix as part of a colon cancer procedure are not eligible for inclusion. * Approach: Natural orifice surgery and endoscopic treatment for suspected appendicitis are excluded. * Previous appendicectomy: Patients having surgery for stump appendicitis are excluded. * Return to theatre: Patients should be entered into study only once. A patient returning to theatre after appendectomy should not be re-entered as a new patient.
Contact & Investigator
Aneel Bhangu
STUDY DIRECTOR
University of Birmingham
Frequently Asked Questions
Who can join the NCT06774001 clinical trial?
This trial is open to participants of all sexes, studying Appendicitis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06774001 currently recruiting?
Yes, NCT06774001 is actively recruiting participants. Contact the research team at t.t.k.anyomih@bham.ac.uk for enrollment information.
Where is the NCT06774001 trial being conducted?
This trial is being conducted at Cotonou, Benin, Tamale, Ghana, Ludhiana, India, Veraruz, Mexico and 3 additional locations.
Who is sponsoring the NCT06774001 clinical trial?
NCT06774001 is sponsored by University of Birmingham. The principal investigator is Aneel Bhangu at University of Birmingham. The trial plans to enroll 14,000 participants.